Company / Operating Income per Share
Elicio Therapeutics, Inc. Operating Income per Share History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.31
FY2022
5-year range
-$3.61 / -$1.31
FY2021-FY2022
Trend
+63.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-1.31 in FY2022.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating income per share increased 63.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.36 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$1.31 | +63.6% |
| FY2021 | -$3.61 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026